Introducing Medisca Nutraceuticals

Download in electronic PDF format for $25



Search the Complete Journal Archives

Evaluation of Extemporaneous Oral Itraconazole Suspensions by Dissolution Profiles Mapping

Author(s):  Tong Henry H Y, Chan Hokman, Du Zhen, Zheng Ying

Issue:  Jul/Aug 2010 - Sterile Compounding
View All Articles in Issue

Abstract:  The objective of this study was to evaluate by dissolution profiles mapping five extemporaneous oral itraconazole suspensions reported in literature. Dissolution profiles of the extemporaneous oral itraconazole preparations were mapped and correlated with their reported clinical data therein. Four out of five extemporaneous preparations had either too early or insufficient release of itraconazole during dissolution study, potentially limiting the in vivo oral bioavailability in patients. Dissolution profile in the remaining extemporaneous preparation was closely similar to that in commercial itraconazole capsules. Based on the reported clinical data and dissolution results in this study, the extemporaneous preparation proposed in a study by Ong and Fobes seems to be the most reasonable choice for our patients. Dissolution profile evaluation is an important quality-control parameter during the evaluation of extemporaneous preparations by pharmacists.

Related Keywords: Henry H.Y. Tong, PhD, RPh, Hokman Chan, BSc, Zhen Du, Mphil, Ying Zheng, PhD, itraconazole oral suspensions, antifungal agents, dissolution profile mapping, stability, bioavailability, literature review, formulations

Related Categories: PEER-REVIEWED, STABILITIES, COMPATIBILITIES, QUALITY CONTROL, DOSAGE FORMS/DRUG CARRIERS, INFECTIOUS DISEASE, LITERATURE REVIEW

Printer-Friendly Version

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
Evaluation of Extemporaneous Oral Itraconazole Suspensions by Dissolution Profiles Mapping Tong Henry H Y, Chan Hokman, Du Zhen, Zheng Ying Jul/Aug 2010 342-345 Buy
Stability of Extemporaneous Oral Ribavirin Liquid Preparation Chan John P, Tong Henry H Y, Chow Alber H L Nov/Dec 2004 486-488 Buy
Wetting and/or Solubilizing Agents, Featured Excipient: Allen Loyd V Jr Jul/Aug 2001 310 Buy
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh Allen Loyd V Jr Nov/Dec 2003 449-450 Buy
Stability of Prednisone in Oral Mix Suspending Vehicle Friciu Mihaela, Plourde Kevin, Leclair GrĂ©goire, Danapoulos Panagiota, Savji Taslim Jul/Aug 2015 337-339 Buy
Stability of Midazolam Intranasal Formulation for the Treatment of Status Epilepticus in Dogs Elder Deborah Lester, Zheng Bo, White Catherine A, Li Dawei Jan/Feb 2011 74-77 Buy
Itraconazole 40-mg/mL Oral Liquid Allen Loyd V Jr Jul/Aug 2006 301 Buy
Formulation and Accelerated Stability Studies for an Extemporaneous Suspension of Amiodarone Hydrochloride Alexander Kenneth S, Thyangarajapuram N Sep/Oct 2003 389-393 Buy
Stability Issues for Compounding Extemporaneously Prepared Oral Formulations for Pediatric Patients Schotik Debora Jan/Feb 2001 9 Buy
Stability of Venlafaxine Immediate-Release Suspensions Donnelly Ronald F, Wong Keith, Goddard Rob, Johanson Christel Jan/Feb 2011 81-84 Buy